← Open Payments lookup

NELLY OKERE: Open Payments

NPI 1326580705 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,249 in 107 payments from 14 companies in 2025. Trend: 2023 $1,621 · 2024 $2,087 · 2025 $2,249

Food & beverage: $2,239Education: $10
CompanyPaymentsAmount
ABBVIE INC.36$565
Otsuka America Pharmaceutical, Inc.12$377
Alkermes, Inc.8$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$258
E.R. Squibb & Sons, L.L.C.11$229
Vanda Pharmaceuticals Inc.9$163
Teva Pharmaceuticals USA, Inc.4$103
Lundbeck LLC3$83
Axsome Therapeutics, Inc.3$59
Takeda Pharmaceuticals U.S.A., Inc.2$37

Products named: VRAYLAR, CAPLYTA, COBENFY, ARISTADA, REXULTI, ABILIFY MAINTENA, FANAPT, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.